| Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
| aatttatttcagAT |
| atttcagATTTGAA |
| -46.1 % |
![]() |
Data for this mutation
| Sample ID | MSH2 | MLH1 | MSH6 | MUTYH | APC |
|---|---|---|---|---|---|
| 29311_29311-00129311-001 | - | - | - | - | - |
| 31_H1617H1617-1H1617-1A | - | - | - | - | - |
| Analysis | Result | Date | Origin | PMID/dbSNP |
|---|---|---|---|---|
| Ex vivo analysis | Splicing reporter minigene pCAS: retention in frame of the last 9 nucleotides of intron 6 (wild type transcript absent) | 22/05/15 | 19 (INSERM U1079-Rouen) | |
| MMR function in tumor cells | MSI-H / MLH1+MSH2-MSH6-PMS2+ (H1617-1) | 9/12/13 | 31 (Montpellier) | |
| Clinical phenotype | Sporadic colorectal cancer < 50 years old (H1617-1) | 9/12/13 | 31 (Montpellier) |
| Biological significance | Date | Comment |
|---|---|---|
| UV | 28/04/14 | --- |